Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manabu Araki

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2014
[Recent advances in the treatment of neuromyelitis optica]Manabu Araki
Neurochemistry International|October 21, 2018
Blockade of IL-6 signaling in neuromyelitis opticaManabu Araki
Brain and Nerve = Shinkei Kenkyu No Shinpo|October 10, 2014
[Use of tocilizumab, an antibody against interleukin-6 receptor, for the treatment of neuromyelitis optica]Takashi Yamamura, Manabu Araki
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|January 5, 2016
[Plasmablast in the pathology of multiple sclerosis]Masakazu Nakamura, Manabu Araki, Takashi Yamamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 16, 2005
[Multiple sclerosis and regulatory cells]Takashi Yamamura, Kazuya Takahashi, Manabu Araki
Current Medicinal Chemistry|October 16, 2008
Synthetic glycolipid ligands for human iNKT cells as potential therapeutic agents for immunotherapyManabu Araki, Sachiko Miyake, Takashi Yamamura
Journal of Clinical Microbiology|October 2, 2002
Japanese spotted fever involving the central nervous system: two case reports and a literature reviewManabu Araki, Katsuya Takatsuka, Junichiro Kawamura, et al.
Therapeutic Advances in Neurological Disorders|August 28, 2018
Application of immunotherapy for neurological manifestations in hypermobile Ehlers-Danlos syndromeManabu Araki, Youwei Lin, Hirohiko Ono, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 13, 2016
Tocilizumab, MS, and NMOSDIngo Kleiter, Ilya Ayzenberg, Manabu Araki, et al.
Current Topics in Medicinal Chemistry|February 18, 2004
NKT cell-stimulating synthetic glycolipids as potential therapeutics for autoimmune diseaseTakashi Yamamura, Katsuichi Miyamoto, Zsolt Illés, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2014
[Recent advances in the treatment of neuromyelitis optica]Manabu Araki
Neurochemistry International|October 21, 2018
Blockade of IL-6 signaling in neuromyelitis opticaManabu Araki
Brain and Nerve = Shinkei Kenkyu No Shinpo|October 10, 2014
[Use of tocilizumab, an antibody against interleukin-6 receptor, for the treatment of neuromyelitis optica]Takashi Yamamura, Manabu Araki
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|January 5, 2016
[Plasmablast in the pathology of multiple sclerosis]Masakazu Nakamura, Manabu Araki, Takashi Yamamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 16, 2005
[Multiple sclerosis and regulatory cells]Takashi Yamamura, Kazuya Takahashi, Manabu Araki
Current Medicinal Chemistry|October 16, 2008
Synthetic glycolipid ligands for human iNKT cells as potential therapeutic agents for immunotherapyManabu Araki, Sachiko Miyake, Takashi Yamamura
Journal of Clinical Microbiology|October 2, 2002
Japanese spotted fever involving the central nervous system: two case reports and a literature reviewManabu Araki, Katsuya Takatsuka, Junichiro Kawamura, et al.
Therapeutic Advances in Neurological Disorders|August 28, 2018
Application of immunotherapy for neurological manifestations in hypermobile Ehlers-Danlos syndromeManabu Araki, Youwei Lin, Hirohiko Ono, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 13, 2016
Tocilizumab, MS, and NMOSDIngo Kleiter, Ilya Ayzenberg, Manabu Araki, et al.
Current Topics in Medicinal Chemistry|February 18, 2004
NKT cell-stimulating synthetic glycolipids as potential therapeutics for autoimmune diseaseTakashi Yamamura, Katsuichi Miyamoto, Zsolt Illés, et al.
Pageof 6